Pharmacists may earn 1.00 CPE Credit (0.10 CEU) by completing this course on the American Society of Health-System Pharmacists (ASHP) website. Please click here to go to the course (you will leave the myCME website, and free registration on the ASHP website is required). Your certificate will save on ASHP.org and will not be included in your myCME CME History.
This continuing medical education activity is provided by the American Society of Health-System Pharmacists (ASHP).
Supported by an educational grant from Merck.
Clostridium difficile infection (CDI) is the most common healthcare associated infection the United States and the most common cause of mortality in patients with gastroenteritis. Treatment of CDI is evolving with a greater emphasis on prevention of recurrence also known as sustained clinical response. These changes will require education to clinicians on these major changes. This session will provide a state-of-the art update on best practice treatment of CDI with a focus on guideline updates, antibiotic stewardship strategies, and sustained clinical response.
This activity was planned to meet the educational needs of physicians, pharmacists, physician assistants, and nurse practitioners involved in the treatment of patients with Clostridium difficile infection (CDI).
At the conclusion of this knowledge-based educational activity, participants should be able to:
Review updates of Clostridium difficile infection (CDI) guideline recommendations
Apply antibiotic stewardship strategies for the primary prevention of CDI
Discuss treatment of CDI with a focus on sustained clinical response
Conflict Of Interest Disclosure Policy
In accordance with ACCME and ACPE Standards for Commercial Support, ASHP policy requires that all faculty, planners, reviewers, staff, and others in a position to control the content of this presentation disclose their financial relationships.
Dr. Rao discloses the following: Research support (Co-investigator): Merck, Inc.
Accredited Provider Disclosure
The planners and managers reported no financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this CME activity.
AMA PRA Category 1 Credit(s)TM
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Society of Health-System Pharmacists designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Unlabeled Use
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
In order to receive credit, participants must view the activity and complete the post-test and program evaluation. Participants must score at least 70% on the post-test. Certificates will be distributed online at the conclusion of the activity. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.
For information about the accreditation of this program, please contact firstname.lastname@example.org.